Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
15.5M
-
Shares change
-
-262K
-
Total reported value, excl. options
-
$194M
-
Value change
-
-$3.2M
-
Number of buys
-
21
-
Number of sells
-
-23
-
Price
-
$12.48
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q4 2020
58 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q4 2020.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.5M shares
of 96M outstanding shares and own 16.16% of the company stock.
Largest 10 shareholders include 5AM Venture Management, LLC (3.37M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.18M shares), Cormorant Asset Management, LP (1.9M shares), BOXER CAPITAL, LLC (1.6M shares), Redmile Group, LLC (1.38M shares), BlackRock Inc. (951K shares), BAKER BROS. ADVISORS LP (636K shares), MILLENNIUM MANAGEMENT LLC (605K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (464K shares), and STATE STREET CORP (200K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.